Chris Eccles

Research Analyst, Associate Director

Chris Eccles is a research analyst who specialises in testing and regulatory affairs. He researches stocks globally and focuses on the Healthcare sector.

Chris joined Impax in March 2019. He started working in the financial industry in 2011 as a research analyst at Morgan Stanley where he focused on European large-cap pharmaceuticals. In 2014, he became a partner at the hedge fund Kola Capital where he worked as a global equities analyst for three years before moving to Stifel in 2017 to work as a Healthcare Specialist.

Chris achieved an MA (Oxon) Physiological Sciences First Class Honours, from the University of Oxford.

Recent blog posts

The sustainable healthcare opportunity

The global healthcare sector is undergoing transformation in the face of demographic change, government regulation, scientific advance and therapeutic innovation.

21 Nov 2019
Scroll to top
User Agent: CCBot/2.0 (